JNJ (Johnson & Johnson) FFO


JNJ Johnson & Johnson JNJ
85 GF Score
Price $244.88
GF Value $190.57
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Johnson & Johnson FFO?

FFO (Funds from operations) only applies to REITs.

JNJ
85GF Score
Johnson & Johnson JNJ
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Johnson & Johnson (JNJ) Overvalued in 2026?

Based on GuruFocus' analysis, Johnson & Johnson stock appears to be overvalued. The current stock price of $244.88 is trading 28.5% above its estimated GF Value™ of $190.57. GuruFocus considers Johnson & Johnson to be Modestly Overvalued.

Key valuation signals for JNJ:

  • FFO:
  • GF Value™: $190.57 vs. price of $244.88 (28.5% above fair value)
  • GF Score™: 85/100 with 7 warning signs

No single metric tells the full story. See the JNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Johnson & Johnson Business Description

Address One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
85GF Score

Get the complete analysis for JNJ

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$244.88
Price
$190.57
GF Value